GSK to buy US cancer treatment firm Nuvalent for $10.6bn
- Posted on June 9, 2026
- By The Guardian
- 0 Views
- 1 min read
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
British drugmaker’s new chief executive Luke Miels announces one of its biggest deals